Abstract
The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Dissecting phenotypic responses of the druggable targetome in cancers
Scientific Reports Open Access 29 August 2019
-
A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives
Scientific Reports Open Access 09 January 2019
-
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Scientific Reports Open Access 11 January 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bunnage, M. E. Getting pharmaceutical R&D back on target. Nature Chem. Biol. 7, 335–339 (2011).
Marshall, J. C. Why have clinical trials in sepsis failed? Trends Mol. Med. 20, 195–203 (2014).
Brennan, F. M. et al. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244–247 (1989).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Edwards, A., Arrowsmith, C., Bountra, C. et al. Preclinical target validation using patient-derived cells. Nat Rev Drug Discov 14, 149–150 (2015). https://doi.org/10.1038/nrd4565
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4565
This article is cited by
-
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Nature Reviews Drug Discovery (2022)
-
A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives
Scientific Reports (2019)
-
Dissecting phenotypic responses of the druggable targetome in cancers
Scientific Reports (2019)
-
Applications of chemogenomic library screening in drug discovery
Nature Reviews Drug Discovery (2017)
-
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Nature Reviews Drug Discovery (2017)